{
    "organizations": [],
    "uuid": "ad06c9fd9d32ae50206fed87d1bed2e3d19c2f73",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gsks-viiv-healthcare-says-filed-pa/brief-gsks-viiv-healthcare-says-filed-patent-infringement-litigation-against-gilead-sciences-idUSFWN1PY04Q",
    "ord_in_thread": 0,
    "title": "BRIEF-GSK's ViiV Healthcare Says Filed Patent Infringement Litigation Against Gilead Sciences",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Glaxosmithkline Plc:\n* VIIV FILES PATENT INFRINGEMENT LITIGATION * GLAXOSMITHKLINE PLC - VIIV ‍ANNOUNCED IT FILED PATENT INFRINGEMENT LITIGATION AGAINST GILEAD SCIENCES INC. OVER BICTEGRAVIR IN UNITED STATES AND CANADA​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T15:17:00.000+02:00",
    "crawled": "2018-02-09T16:45:53.033+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "glaxosmithkline",
        "plc",
        "viiv",
        "file",
        "patent",
        "infringement",
        "litigation",
        "glaxosmithkline",
        "plc",
        "viiv",
        "filed",
        "patent",
        "infringement",
        "litigation",
        "gilead",
        "science",
        "bictegravir",
        "united",
        "state",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}